Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
University of Oxford · Glasgow Caledonian University · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,035
total citations
- FWCI
- 55.14
- Percentile
- 100%
- References
- 23
Citations per year
Authors
38Topics & keywords
Topics
Keywords
- Medicine
- Tamoxifen
- Breast cancer
- Internal medicine
- Oncology
- Cancer
- Adverse effect
- Gynecology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.